Transcriptional Regulation of the p53 Tumor Suppressor Gene: A Potential Target for Cancer Therapeutics?

Publisher： Bentham Science Publishers

E-ISSN： 2212-3431|1|3|176-185

ISSN： 1872-2156

Source： Recent Patents on DNA & Gene Sequences, Vol.1, Iss.3, 2007-11, pp. : 176-185

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Monoclonal Antibodies as Cancer Therapeutics

By  

Recent Patents on Biotechnology, Vol. 6, Iss. 1, 2012-04 ,pp. : 45-56

Bentham Science Publishers

Access to resources Recommend Favorite

Potential of Microemulsions in Drug Delivery and Therapeutics: A Patent Review

By  

Recent Patents on Drug Delivery & Formulation, Vol. 2, Iss. 2, 2008-06 ,pp. : 136-144

Bentham Science Publishers

Access to resources Recommend Favorite

Nanoparticles for Improved Therapeutics and Imaging in Cancer Therapy

By  

Recent Patents on Nanotechnology, Vol. 4, Iss. 3, 2010-11 ,pp. : 171-180

Bentham Science Publishers

Access to resources Recommend Favorite

Isocitrate Lyase: A Potential Target for Anti-Tubercular Drugs

By  

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 7, Iss. 2, 2013-05 ,pp. : 114-123

Bentham Science Publishers

Access to resources Recommend Favorite

Mitochondria in Cancer Stem Cells: A Target for Therapy

By  

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 7, Iss. 2, 2013-05 ,pp. : 102-114

Bentham Science Publishers

Access to resources Recommend Favorite